Jazz Pharmaceuticals plc (JAZZ) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

JAZZ rapporto: 71%

100%

JAZZ supera 25 di 35 ultime stime

Data del prossimo reportNov 13, 2024

Stimato per Q4 24:$4.51

Cambiamenti implicati per il Q3 24:-3.43%

Cambiamenti implicati per il Q4 23:+6.87%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q3 24	Nov 6, 2024	$5.86 / $4.54	$1.32 / 29.07%
Q2 24	Jul 31, 2024	$4.67 / $3.8	$0.87 / 22.89%
Q1 24	May 1, 2024	$1.98 / $3.53	$-1.55 / -43.91%
Q4 23	Feb 28, 2024	$4.4 / $4.44	$-0.04 / -0.9%
Q3 23	Nov 8, 2023	$4.22 / $4.21	$0.01 / 0.24%
Q2 23	Aug 9, 2023	$3.83 / $3.68	$0.15 / 4.08%
Q1 23	May 10, 2023	$3.2 / $3.58	$-0.38 / -10.61%
Q4 22	Mar 1, 2023	$-0.84 / $-	$-0.84 / -

Fornitori di Dati: Xignite Logo